Myocardial metabolites such as adenosine mediate reactive hyperemia, in part, by activating ATP-dependent K ϩ (KATP) channels in coronary smooth muscle. In this study, we investigated the role of adenosine A2A and A2B receptors and their signaling mechanisms in reactive hyperemia. We hypothesized that coronary reactive hyperemia involves A2A receptors, hydrogen peroxide (H2O2), and KATP channels. We used A2A and A2B knockout (KO) and A2A/2B double KO (DKO) mouse hearts for Langendorff experiments. Flow debt for a 15-s occlusion was repaid 128 Ϯ 8% in hearts from wild-type (WT) mice; this was reduced in hearts from A2A KO and A2A/2B DKO mice (98 Ϯ 9 and 105 Ϯ 6%; P Ͻ 0.05), but not A2B KO mice (123 Ϯ 13%). Patch-clamp experiments demonstrated that adenosine activated glibenclamide-sensitive KATP current in smooth muscle cells from WT and A2B KO mice (90 Ϯ 23% of WT) but not A2A KO or A2A/A2B DKO mice (30 Ϯ 4 and 35 Ϯ 8% of WT; P Ͻ 0.05). Additionally, H2O2 activated KATP current in smooth muscle cells (358 Ϯ 99%; P Ͻ 0.05). Catalase, an enzyme that breaks down H2O2, attenuated adenosine-induced coronary vasodilation, reducing the percent increase in flow from 284 Ϯ 53 to 89 Ϯ 13% (P Ͻ 0.05). Catalase reduced the repayment of flow debt in hearts from WT mice (84 Ϯ 9%; P Ͻ 0.05) but had no effect on the already diminished repayment in hearts from A2A KO mice (98 Ϯ 7%). Our findings suggest that adenosine A2A receptors are coupled to smooth muscle KATP channels in reactive hyperemia via the production of H2O2 as a signaling intermediate. in reactive hyperemia has been provided by studies of the reactive dilation of isolated coronary arterioles (18) and mesenteric reactive hyperemia (49). Additionally, it is reported that K ATP channels mediate, to some degree, H 2 O 2 -induced dilation of arterioles from skeletal muscle and brain (24, 44). Thus we determined whether H 2 O 2 couples adenosine receptor stimulation to K ATP channel activity in coronary reactive hyperemia.
obfuscates their relative contribution. This issue could be resolved with the gene-targeted approaches we have used previously to demonstrate pivotal roles for A 2A receptors in the regulation of coronary vascular function (28, 39, 41) . Thus, to specifically determine the roles of A 2A and A 2B ARs in coronary reactive hyperemia, in addition to distinguishing their role from A 1 and A 3 ARs, we used Langendorff-perfused hearts from wild-type (WT), A 2A knockout (KO), A 2B KO, and A 2A/2B double knockout (DKO) mice, respectively.
Numerous mediators and end effectors of coronary reactive hyperemia have been proposed to function downstream of adenosine receptors, including H 2 O 2 and ATP-dependent K ϩ (K ATP ) channels. The role of K ATP channels in coronary reactive hyperemia is firmly established (3, 12) , while the contribution of H 2 O 2 and interactions with K ATP channels are less clear. Some support for H 2 O 2 in reactive hyperemia has been provided by studies of the reactive dilation of isolated coronary arterioles (18) and mesenteric reactive hyperemia (49) . Additionally, it is reported that K ATP channels mediate, to some degree, H 2 O 2 -induced dilation of arterioles from skeletal muscle and brain (24, 44 ). Thus we determined whether H 2 O 2 couples adenosine receptor stimulation to K ATP channel activity in coronary reactive hyperemia.
MATERIALS AND METHODS
Animals. An Institutional Animal Care and Use Committee at West Virginia University School of Medicine approved all experimental protocols. We followed guidelines set forth by the American Physiological Society and National Institutes of Health regarding the care and use of laboratory animals. A 2A and A2B KO mice, both backcrossed 12 generations to the WT C57BL/6 background (Jackson Laboratory; Bar Harbor, ME), were bred to generate A 2A/A2B double heterozygotes. Double heterozygotes were intercrossed, 1/16 of the offspring were A 2A/A2B DKO, and A2A/A2B knockout breeding pairs were established. Mice were caged in a 12:12-h light-dark cycle with free access to standard chow and water.
Langendorff-perfusion. Mice (10 -14 wk) were anesthetized with pentobarbital sodium (50 mg/kg ip) and hearts were excised into heparinized (5 U/ml) ice-cold Krebs-Henseleit buffer containing (in mM) 119 NaCl, 11 glucose, 22 NaHCO 3, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 2 pyruvate, and 0.5 EDTA. Hearts beat spontaneously when retrogradely perfused (80 mmHg) with 37°C buffer bubbled with 95% O 2-5% CO2. The left atrium was removed and the left ventricle drained. A fluid-filled balloon was inserted into the left ventricle and connected to a transducer for pressure measurements. Left ventricular diastolic pressure was adjusted to 2-5 mmHg. Coronary flow was measured with a probe (Transonic Systems; Ithaca, NY) in the aortic perfusion line. Hearts were paced to 420 beats/min and function allowed to stabilize. Hearts with persistent arrhythmias or developed pressure less than 80 mmHg were excluded from the study. Coronary flow and cardiac function were measured using a Power Lab data acquisition system (AD Instruments; Colorado Springs, CO). Hearts were subjected to 15 s of total flow occlusion to elicit hyperemia. Catalase, glibenclamide, and N -nitro-L-arginine methyl ester (L-NAME) (Sigma Chemical; St. Louis, MO) were delivered into the aortic perfusion line using a microinjection pump (Harvard Apparatus; Holliston, MA) as 1% of coronary flow to achieve a final concentration of 1,250 U/ml (46, 49) .
Patch clamp. Single smooth muscle cells were enzymatically isolated from mouse aortas. For cell isolation, a HEPES-buffered saline was used and contained (in mM) 135 NaCl, 5 KCl, 1 MgCl 2, 0.36 CaCl2, 10 glucose, 10 HEPES, and 5 Tris; pH 7.4. The aorta was placed in this solution plus (in mg/ml) 2 collagenase, 1 elastase, 2 bovine serum albumin, and 1 soybean trypsin inhibitor for 15 min at 37°C. The tissue was passed through the tip of a fire-polished Pasteur pipette to liberate single cells. Smooth muscle cells were resuspended in enzyme-free buffer, stored on ice, and used within 8 h. Cells were placed in a recording chamber atop an inverted microscope and perfused with a HEPES-buffered solution containing 140 mM K ϩ . Patch pipettes (3-5 M⍀) were filled with 140 mM K ϩ solution supplemented with 5 mM Mg-ATP and 0.1 mM Na-GTP, pH 7.1. Inward KATP currents were recorded in the conventional whole cell mode (with Nernst equilibrium potential for K ϩ set to 0 mV). The membrane potential was held at Ϫ80 mV and ramped or stepped to potentials between Ϫ100 and ϩ100 mV. Currents were low-pass filtered at 1 kHz and digitized at 5 kHz. Series resistance and whole cell capacitance were compensated as completely as possible through the amplifier (PC-505, Warner Instruments; Hamden, CT). This amplifier was interfaced to a computer with pClamp 9 software for data acquisition and analysis (Molecular Devices; Sunnyvale, CA). All currents are reported as glibenclamide-sensitive K ATP conductance (and calculated as nS/pF); effects of drugs are represented relative to control.
Flow debt (equal to baseline flow rate ϫ occlusion time) and repayment area [equal to integral of hyperemic area above baseline flow during the first minute of reactive hyperemia] were calculated as previously reported (6, 10, 51) . Since absolute coronary flow rates change proportionally with heart mass and metabolic rate, the repayment area and debt area data are represented as milliliters per gram of wet heart weight (ml/g) and baseline and peak flow data are presented as milliliters per minute per gram of wet heart weight (ml·min Ϫ1 ·g Ϫ1 ). Each reactive hyperemia graph represents the average of all studies.
Statistical analysis. Statistical analyses were made with t-test and one-way analysis of variance (ANOVA) as indicated. Results were considered significant when P Ͻ 0.05. Values are means Ϯ SE from n number of animals.
RESULTS
A 2A receptors are important in coronary reactive hyperemia. We used hearts from WT, A 2A and A 2B KO mice to test the involvement of adenosine receptor subtypes in coronary reactive hyperemia. Hearts from A 2A/2B DKO mice were used to test the combined role of A 2A and A 2B ARs known to induce coronary vasodilation. Baseline flow in WT hearts (n ϭ 6) was 19.8 Ϯ 0.9 ml·min Ϫ1 ·g Ϫ1 , and 4.9 Ϯ 0.2 ml/g of flow debt was incurred during a 15-s occlusion. Peak hyperemic flow was 42.7 Ϯ 2.0 ml·min Ϫ1 ·g Ϫ1 , and the repayment volume was 6.3 Ϯ 0.4 ml/g. Thus flow debt was repaid 128 Ϯ 8% in hearts from WT mice (Fig. 1) . Repayment volume was reduced in A 2A KO mice (n ϭ 8; Fig. 1 ). Specifically, while baseline flow (19.4 Ϯ 1.6 ml·min Ϫ1 ·g
Ϫ1
), debt volume (4.9 Ϯ 0.4 ml/g), and peak flow (42.9 Ϯ 1.7 ml·min Ϫ1 ·g Ϫ1 ) were similar to WT, the repayment volume was only 4.5 Ϯ 0.2 ml/g (P Ͻ 0.05 vs. WT). That is, flow debt was repaid only 98 Ϯ 9% in hearts from A 2A KO mice (just 77 Ϯ 7% of the response seen in WT).
In contrast, hyperemic responses in hearts from A 2B KO mice (n ϭ 5) were indistinguishable from those in WT (Fig. 1 ). There were no differences in baseline flow (20. 
), or repayment volume (6.1 Ϯ 0.1 ml/g). Flow debt in hearts from A 2B KO mice was repaid (123 Ϯ 13%), representing 95 Ϯ 9% of the response in hearts from WT mice. Responses in hearts from A 2A/2B DKO mice (n ϭ 8) were similar to A 2A KO mice (Fig. 1 ). That is, repayment volume (4.9 Ϯ 0.2 ml/g) and the repayment of flow debt (105 Ϯ 6%) were reduced (P Ͻ 0.05 vs. WT). Resting flow (18.6 Ϯ 0.6 ml·min Ϫ1 ·g Ϫ1 ), debt volume (4.7 Ϯ 0.1 ml/g), and peak flow (.6 Ϯ 1.2 ml·min Ϫ1 ·g Ϫ1 ) were not different from WT, but the repayment of flow debt in hearts from A 2A/2B DKO mice was only 82 Ϯ 5% of the response seen in WT (Table 1) .
Adenosine activates K ATP channels through A 2A receptors. We tested the effect of K ATP channel blockade on coronary reactive hyperemia response of WT isolated hearts. Glibenclamide (10 M) significantly reduced WT (n ϭ 5) baseline flow from 17.3 Ϯ 0.5 to 12.8 Ϯ 0.5 ml·min Responses were similar in hearts from wild-type (WT) (n ϭ 6) and A2B knockout (KO) (n ϭ 5) mice, but were significantly reduced in hearts from A2A KO (n ϭ 6) and A2A/A2B double knockout (DKO) (n ϭ 8) mice. B: repayment of flow debt was reduced 22-29% in A2A KO and A2A/A2B DKO mice (*P Ͻ 0.05 vs. WT by one-way ANOVA; detailed in text) but not in A2B KO (n ϭ 5).
0.4 ml/g, respectively. Thus flow debt was repaid 161 Ϯ 12% in hearts from WT mice while this was reduced to 87.5 Ϯ 11.2% in the presence of glibenclamide (Fig. 2) .
We isolated smooth muscle cells from the aortas of WT, A 2A and A 2B KO, and A 2A/2B DKO mice and used whole cell patch-clamp to determine whether A 2A receptors couple to K ATP channels. Recordings were made in symmetrical 140 mM K ϩ so that inward linear K ATP current was more easily resolved. Effects of adenosine (10 M) were compared with pinacidil (10 M) as a positive control. Further, adenosineactivated currents were blocked with glibenclamide (10 M) to confirm that K ATP channels mediated them. Adenosine activated current in smooth muscle cells from WT mice (Fig. 3A) , but not A 2A KO mice (Fig. 3B) . Responses in smooth muscle cells from A 2B KO mice (Fig. 3C) were similar to WT, while responses in cells from A 2A/2B DKO mice (Fig. 3D) were like those from A 2A KO mice. Group data (cells from n ϭ 4 -5 mice in each group; Fig. 3E) show that adenosineinduced K ATP current was diminished in smooth muscle cells from mice lacking the adenosine A 2A receptor (P Ͻ 0.05 vs. WT by one-way ANOVA). Importantly, however, functional K ATP channel expression was not different as pinacidil-activated K ATP current was similar in smooth muscle cells from all four strains of mice.
H 2 O 2 activates K ATP current in smooth muscle. We isolated smooth muscle cells from the aortas of WT mice and used whole cell patch clamp to determine whether H 2 O 2 activates K ATP current. Current was recorded in the symmetrical 140 mM K ϩ solutions described above. Figure 4A shows current sensitive to glibenclamide (10 M) under control conditions and when activated by H 2 O 2 (1 mM) and pinacidil (10 M). Group data (cells from n ϭ 5 mice) are shown in Fig. 4B ; K ATP conductance (nS/pF) was 0.018 Ϯ 0.006 under control conditions and significantly increased to 0.070 Ϯ 0.026 and 0.142 Ϯ 0.033 with 1 mM H 2 O 2 and with 10 M pinacidil, respectively (both P Ͻ 0.05 vs. control by one-way ANOVA). To determine the role of K ATP channels in H 2 O 2 -mediated coronary vasodilation, we examined the effect of glibenclamide (10 M) on changes in flow induced by H 2 O 2 (10 M). In our isolated heart system, glibenclamide significantly decreased the baseline coronary flow (79 Ϯ 6%) and consistent with the patchclamp data, our data showed that glibenclamide significantly reduced the H 2 O 2 -induced increase in coronary flow from 164 Ϯ 16 to 79 Ϯ 6% (n ϭ 4, Fig. 4C ).
Adenosine-induced coronary dilation involves H 2 O 2 . We used catalase to determine the role of endogenous H 2 O 2 production in adenosine-induced coronary vasodilation. Adenosine-induced coronary vasodilation is catalase-sensitive (Fig. 5A) , indicating a role for endogenous H 2 O 2 production. Specifically, adenosine (1 M) increased coronary flow (284 Ϯ 53%) and catalase (1,250 U/ml) reduced the baseline flow to 86 Ϯ 2%; however, catalase reduced the adenosine response to 89 Ϯ 13% (P Ͻ 0.05 vs. control by paired t-test). Catalase reduced left ventricular developed pressure (Fig. 5C ), but had no effect on heart rate (Fig. 5B) . These data suggest that 1) H 2 O 2 is involved in adenosine-mediated effects on cardiac contractility or 2) cardiac function decreased secondary to a reduction in coronary flow. Since we have previously shown that adenosine does not increase the coronary flow in A 2A/2B KO mice (39) to degrade H 2 O 2 (Fig. 6 ). In hearts from WT mice, catalase significantly decreased the repayment of flow debt (from 128 Ϯ 8 to 84 Ϯ 9%; P Ͻ 0.05; n ϭ 6). In hearts from A 2A KO mice, catalase had no effect on the already diminished repayment of flow debt (98 Ϯ 9 vs. 98 Ϯ 7%; n ϭ 6, Table 1 ).
H 2 O 2 contributes to coronary reactive hyperemia independent of nitric oxide (NO).
Adenosine A 2A and A 2B receptors can also signal through NO (32) . NO is a well-known vasodilator involved in regulating baseline coronary flow and reactive hyperemia. Thus, to separate the role of H 2 O 2 from NO, we performed reactive hyperemia experiments on hearts from WT mice with L-NAME (50 M, a NO synthase inhibitor) and L-NAME plus catalase (Fig. 7) . L-NAME significantly decreased the repayment of flow debt (73 Ϯ 8% of control; n ϭ 5, P Ͻ 0.05). Importantly, however, addition of catalase to L-NAME further reduced the repayment of flow debt (57 Ϯ 9%; P Ͻ 0.05). These data indicate that the effect of catalase is on H 2 O 2 signaling, not NO signaling.
DISCUSSION
Our study provides several new substantial lines of evidence regarding mechanisms of coronary reactive hyperemia. First, using gene-targeted mice, we offer a definitive comparison of the roles of A 2A and A 2B receptors in coronary reactive hyperemia. Our finding that A 2A receptor plays a dominant role in adenosine-mediated coronary reactive hyperemia substantially advances knowledge gained from studies using adenosine receptor antagonists (6, 10, 51) . Second, with our catalase experiments, we provide the first evidence of a role for H 2 O 2 in reactive hyperemia in the intact heart. These data add significantly to previous observations of roles for H 2 O 2 in mesenteric reactive hyperemia (49) and reactive dilation in isolated coronary arterioles (18) . Third, through a combination of experiments, we offer the original observation that H 2 O 2 couples A 2A receptor stimulation to K ATP channel activation in coronary reactive hyperemia.
Previously, two general strategies have been employed to determine the role of adenosine and its receptors in coronary reactive hyperemia: 1) enzymatic degradation of adenosine (e.g., infusing adenosine deaminase) or 2) pharmacological antagonism of adenosine receptors (e.g., administering aminophylline). With these tools, it had been demonstrated previously that adenosine plays a small, but significant role, in coronary reactive hyperemia in dogs, lambs, and pigs (4, 6, 10, 23). Because two of the four known adenosine receptor subtypes, A 2A and A 2B , are linked to coronary vasodilation, a logical question centers on which receptor subtype(s) is/are involved. Gene deleted knockout mice have been an important tool to dissect physiological signaling pathways, e.g., elucidating the role of receptor through its absence. Using PCR, we confirmed the absence of A 2A and A 2B receptors in knockout mouse tail, aorta and coronary arteries (data not shown). Therefore, the present results obtained using adenosine receptor knockout mice support the view that adenosine and the A 2A receptor mediate a portion of coronary reactive hyperemia.
A 2A and A 2B receptors both function in signaling in coronary smooth muscle and endothelium (31, 37, 40) , but the relative role of these two receptor subtypes in coronary reactive hyperemia has remained, until now, obscure. Using an antagonist of A 2A receptors (SCH58261), it was suggested that 30 -50% of flow repayment could be attributed to A 2A receptor activation (6, 51) . Our results with hearts from A 2A KO and A 2A / 2B DKO mice indicate that the A 2A receptor is responsible for 22-29% of flow repayment, which is toward the lower end of the previous pharmacological estimates. Our results from A 2B KO and A 2A/2B DKO mice did not suggest a significant role for A 2B receptors in reactive hyperemia, similar to previous pharmacological studies (6, 51) . Due to its low affinity for adenosine, A 2B receptors are thought to be activated under more severely ischemic conditions, such as during ischemia/ reperfusion and preconditioning (13, 15) . We tested the involvement of H 2 O 2 in reactive hyperemia and adenosine-induced coronary vasodilation. We demonstrate that catalase, which breaks down H 2 O 2 into water and oxygen, significantly attenuates adenosine-induced coronary vasodilation. This suggests that H 2 O 2 plays a critical role in adenosine- mediated signaling pathways. We also demonstrate that the repayment of flow debt was reduced by catalase, showing the contribution of endogenous H 2 O 2 production to coronary reactive hyperemia. Furthermore, we suggest that H 2 O 2 released during coronary reactive hyperemia is, at least partly, mediated through activation of A 2A adenosine receptors since catalase did not further decrease the flow repayment in A 2A KO hearts. This is not likely due to changes in H 2 O 2 degradation in A 2A KO mice, as the concentration-response curve to exogenous H 2 O 2 (100 nM to 80 M) is unchanged compared with WT control or A 2B KO (data not shown). In the vasculature, NAD(P)H oxidases (Nox) are responsible for the majority of ROS production (21) . Nox4 is shown to be the dominant isoform producing H 2 O 2 and also expressed in vascular smooth muscle cells (45) . Therefore, expression level of factors involved in vascular H 2 O 2 production such as NOX4 in A 2A KO remain to be examined in future studies. Nevertheless, the idea that H 2 O 2 is a mediator of coronary metabolic (36, 48) and endothelium-dependent (22, 27) vasodilation is gaining traction; however, no previous study had indicated a role for H 2 O 2 in intact coronary reactive hyperemia. Two related observations had, however, been made in other vascular beds. Video microscopy of the cremasteric microcirculation indicated striking similarities in the pharmacological sensitivity of reactive hyperemia and exogenous H 2 O 2 (46) . A study using microspheres in the mouse mesenteric circulation indicated that ϳ40% of hyperemic flow was catalase-sensitive, i.e., attributable to endogenous H 2 O 2 production (49). Our data are in agreement and indicate that ϳ35% of hyperemic flow in the mouse heart is catalase-sensitive. We demonstrated previously that A 2A -mediated coronary vasodilation depends upon K ATP channels, as it is blocked by Perhaps a better approach would be to study smooth muscle cells isolated from mouse coronary arteries or arterioles. This is because differences between large-and small-caliber vessels exist (e.g., effects on intravascular pressure and relative responses to metabolic, neurohumoral, myogenic, and flowmediated mechanisms) (7, 11) . Moreover, it has been demonstrated that differences in K ϩ channel expression may explain some segmental differences in vascular reactivity (1, 25) . Importantly, however, there is no a priori reason to assume that, in this context, K ATP channels in smooth muscle cells from the aorta and coronary arterioles would respond differently to adenosine and H 2 O 2 signaling. Specifically, both conduit and resistance arteriolar smooth muscle cells express K ATP channels (17, 19) , adenosine A 2 receptors (9, 47), and relax or dilate to H 2 O 2 (26, 27) . In fact, we demonstrate here that K ATP electrophysiology from aortic smooth muscle cells (Figs. 3 and 4 ) matches very well with functional responses from coronary resistance vessels (Fig. 4C) . Thus, until demonstrated otherwise, it is justifiable to conclude that aortic smooth muscle cells serve as an excellent electrophysiological model for coronary arteriolar dilation, at least with regard to WT L-NAME L-NAME + Catalase A B Fig. 7 . Catalase-sensitive portion of reactive hyperemia is independent of nitric oxide. A (n ϭ 4 -9) shows group data of baseline flow and hyperemic responses in hearts from WT mice in the presence and absence of N -nitro-L-arginine methyl ester (L-NAME) (5 ϫ 10 Ϫ5 M, nitric oxide synthase inhibitor) or L-NAME ϩ catalase (1,250 U/ml). B shows the further reduced hyperemic response in the presence of both L-NAME and catalase (68.5%) relative to L-NAME alone (53.1%) compared with WT. *P Ͻ 0.05 and #P Ͻ 0.05 vs. control and L-NAME effect, respectively. . Hyperemic responses were reduced by catalase in hearts from WT (n ϭ 7) but not A2A KO (n ϭ 6) mice. Catalase reduced the repayment of flow debt 30% in hearts from WT (B) mice (*P Ͻ 0.05 by unpaired t-test), but had no effect in hearts from A2A KO mice (C).
adenosine signaling, reactive oxygen species, and K ATP channel regulation. With regard to the limitations of our study, since we have used isolated heart system, the contribution of flow/shear stress-or pressure-dependent coronary mechanisms in the development of reactive hyperemia could not be clearly elucidated or isolated from the effect of local metabolic factors. Additionally, Krebs buffer used in crystalloid-perfused mouse heart, unlike blood, does not have O 2 -carrying capacity and hence some may suggest that the heart would be ischemic (by definition) or hypoxic compared with circulating blood. Regardless, constantly oxygenated ex vivo isolated heart model is a well-established method that has been used to answer mechanistic questions. Data gathered from isolated heart reflect the overall end effect of shear/pressure stress-and metabolitesinduced effects via eliminating the complexity of the role of neuronal and hormonal effects during coronary reactive hyperemia, thus allowing a better understanding of the coronary flow regulation.
Our study provides novel data to further understand mechanisms of coronary reactive hyperemia and adenosine-induced vasodilation. Using adenosine receptor KO mice, we show that A 2A receptors, but not A 2B receptors, are critical to coronary reactive hyperemia. This finding supports and extends previous studies using pharmacological tools. Additionally, we demonstrate a role for H 2 O 2 in reactive hyperemia in the intact heart. This finding supports observations made in the microcirculation of skeletal muscle and brain and represents the first such report for the coronary circulation. Finally, our data suggest that H 2 O 2 is a signaling molecule coupling the stimulation of A 2A receptors to the opening of K ATP channels. This finding is entirely novel and will require additional research to unravel molecular mechanisms linking A 2A receptor activation to H 2 O 2 production and finally to K ATP channel opening. At present, a list of likely mechanisms might include A 2A -induced activation of NADPH oxidases (14), bioconversion of superoxide to H 2 O 2 , and redox regulation of the K ATP channel or proteins that regulate it (50).
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